Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance. (Q53123731)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance. (English)

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

0 references

1 reference

based on heuristic

inferred from title

chronic myelomonocytic leukemia

1 reference

based on heuristic

inferred from title

Rhett P. Ketterling

7

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

9

object named as

Ayalew Tefferi

1 reference

Europe PubMed Central

11 May 2018

author name string

Mrinal M Patnaik

1

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Terra L Lasho

2

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Christy M Finke

3

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Curtis A Hanson

4

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Janice M Hodnefield

5

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Ryan A Knudson

6

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Animesh Pardanani

8

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

publication date

18 January 2013

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

American Journal of Hematology

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

88

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

3

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

201-206

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Risk assessment in chronic myelomonocytic leukemia (CMML).

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Frequent pathway mutations of splicing machinery in myelodysplasia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Cytogenetic risk stratification in chronic myelomonocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

SR proteins in vertical integration of gene expression from transcription to RNA processing to translation

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

TET2 mutations in myelodysplasia and myeloid malignancies

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23373

21 January 2018

Identifiers

10.1002/AJH.23373

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/23335386

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53123731&oldid=1534906735"